Two Sigma Securities’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,159
| Closed | -$313K | – | 1468 |
|
|
2025
Q1 | $313K | Buy |
1,159
+42
| +4% | +$11.3K | 0.05% | 562 |
|
|
2024
Q4 | $263K | Buy |
+1,117
| New | +$263K | 0.03% | 610 |
|
|
2024
Q3 | – | Sell |
-54,142
| Closed | -$13.2M | – | 1559 |
|
|
2024
Q2 | $13.2M | Buy |
+54,142
| New | +$13.2M | 0.16% | 33 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1421 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1426 |
|
|
2023
Q3 | – | Sell |
-5,111
| Closed | -$971K | – | 1356 |
|
|
2023
Q2 | $971K | Buy |
5,111
+3,590
| +236% | +$682K | 0.01% | 190 |
|
|
2023
Q1 | $305K | Sell |
1,521
-2,467
| -62% | -$494K | 0.01% | 591 |
|
|
2022
Q4 | $948K | Buy |
3,988
+881
| +28% | +$209K | 0.03% | 179 |
|
|
2022
Q3 | $622K | Sell |
3,107
-8,183
| -72% | -$1.64M | 0.02% | 297 |
|
|
2022
Q2 | $1.65M | Buy |
11,290
+3,782
| +50% | +$552K | 0.06% | 63 |
|
|
2022
Q1 | $1.23M | Buy |
7,508
+5,383
| +253% | +$879K | 0.04% | 142 |
|
|
2021
Q4 | $360K | Buy |
+2,125
| New | +$360K | 0.02% | 361 |
|
|
2021
Q3 | – | Sell |
-2,066
| Closed | -$350K | – | 837 |
|
|
2021
Q2 | $350K | Buy |
+2,066
| New | +$350K | 0.01% | 293 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 584 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 668 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 505 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 573 |
|
|
2020
Q1 | – | Sell |
-2,404
| Closed | -$277K | – | 628 |
|
|
2019
Q4 | $277K | Buy |
+2,404
| New | +$277K | ﹤0.01% | 439 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 870 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 838 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1150 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1169 |
|
|
2018
Q2 | – | Sell |
-2,524
| Closed | -$301K | – | 1037 |
|
|
2018
Q1 | $301K | Buy |
+2,524
| New | +$301K | ﹤0.01% | 628 |
|
|
2017
Q4 | – | Sell |
-2,039
| Closed | -$240K | – | 1023 |
|
|
2017
Q3 | $240K | Sell |
2,039
-1,413
| -41% | -$166K | 0.02% | 442 |
|
|
2017
Q2 | $275K | Buy |
+3,452
| New | +$275K | 0.05% | 389 |
|